Mast cells selectively target large cholangiocytes during biliary injury via H2HR‐mediated cAMP/pERK1/2 signaling
Tianhao Zhou,Vik Meadows,Debjyoti Kundu,Konstantina Kyritsi,Travis Owen,Ludovica Ceci,Guido Carpino,Paolo Onori,Eugenio Gaudio,Nan Wu,Shannon Glaser,Burcin Ekser,Gianfranco Alpini,Lindsey Kennedy,Heather Francis
DOI: https://doi.org/10.1002/hep4.2026
2022-07-20
Hepatology Communications
Abstract:In our study, we demonstrated that during liver injury, paracrine crosstalk between cholangiocytes and MCs is regulated by MC‐H2HR that promotes cholestatic phenotypes in primary sclerosing cholangitis (PSC). There is an association between MCs and large intrahepatic bile duct mass (IBDM) and senescence, suggesting that MCs preferentially interact with large cholangiocytes during damage. Moreover, large cholangiocyte‐MC crosstalk influences inflammation and peribiliary fibrosis, preferentially around large ducts. Inhibition of MC‐H2HR ameliorates cholestatic damage by decreasing large IBDM, biliary senescence, hepatic fibrosis, and inflammation. In our study we have utilized several mouse models of cholestatic injury along with correlation in human PSC samples to increase clinical relevance. Bile ducts are heterogenous in structure and function, and primary sclerosing cholangitis (PSC) damages specific bile ducts leading to ductular reaction (DR), mast cell (MC) infiltration, increased histamine release, inflammation, and fibrosis. Bile duct ligation (BDL) induces large duct damage via cyclic adenosine monophosphate (cAMP)/extracellular signal‐related protein kinase (ERK) signaling, and large cholangiocytes express H2 histamine receptor (H2HR). We evaluated how MCs interact with large cholangiocytes during cholestasis. Male wild‐type (WT) and MC‐deficient (KitW‐sh) mice 10–12 weeks of age were subjected to BDL for 7 days. Select KitW‐sh mice were injected with MCs pretreated with control or H2HR antagonist (ranitidine, 25 μm, 48 h) via tail vein injection. In vitro, MC migration toward small mouse cholangiocytes (SMCCs) and large mouse cholangiocytes (LMCCs) treated with lipopolysaccharide or histamine (±ranitidine) was measured. LMCCs were stimulated with MC supernatants pretreated with control, α‐methyl‐dl‐histidine (to block histamine release), or ranitidine. Liver damage, large duct DR/senescence, inflammation, fibrosis, and cAMP/ERK immunoreactivity increased in BDL WT and KitW‐sh+MC mice but decreased in BDL KitW‐sh and KitW‐sh+MC‐H2HR mice. In vitro, MCs migrate toward damaged LMCCs (but not SMCCs) blocked by inhibition of H2HR. Loss of MC histamine or MC‐H2HR decreases LMCC proliferation, senescence, H2HR, and cAMP/ERK levels. Human PSC livers have increased MC number found near DR, senescent ducts, and H2HR‐positive ducts. Conclusion: Infiltrating MCs preferentially interact with large ducts via H2HR signaling promoting biliary and liver damage. Mediation of MCs may be a therapeutic strategy for PSC.
gastroenterology & hepatology